Citius Pharmaceuticals 株価情報 (NASDAQ: CTXR)

Citius Pharmaceuticals (NASDAQ:CTXR) 株価情報

CITIUS PHARMACEUTICALS INC

Citius Pharma

Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.

Citius Pharmaceuticals, Inc. - Common Stock

Citius Pharmaceuticals Inc

News

General

Lithium Americas Enters Equity Distribution Agreement With TD Securities; Company May Sell Up To $100M In Common Shares

Molecular Partners (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOLN#NASDAQ">MOLN</a>) reported quarterly earnings of $0.51 per share.

Earnings

MOLN

Molecular Partners Q1 EPS $0.51

Pioneer Power Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PPSI#NASDAQ">PPSI</a>) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimate of $(0.04) by 125 percent. This is a 10 percent increase over losses of $(0.10) per share from the same period last year. The company reported quarterly sales of $6.74 million which beat the analyst consensus estimate of $6.60 million by 2.16 percent. This is a 103.32 percent increase over sales of $3.31 million the same period last year.

Earnings Beats

Earnings Misses

PPSI

Pioneer Power Solutions Q1 EPS $(0.09) Misses $(0.04) Estimate, Sales $6.74M Beat $6.60M Estimate

Mawson Infra Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MIGI#NASDAQ">MIGI</a>) reported quarterly losses of $(0.02) per share. This is a 98.32 percent increase over losses of $(1.19) per share from the same period last year. The company reported quarterly sales of $13.81 million which missed the analyst consensus estimate of $15.70 million by 12.01 percent. This is a 26.41 percent decrease over sales of $18.77 million the same period last year.

MAWSON INFRSTRUCTURE GRP by Mawson Infrastructure Group Inc.

MIGI

Mawson Infra Gr Q1 EPS $(0.02) Up From $(1.19) YoY, Sales $13.81M Miss $15.70M Estimate

Virgin Galactic Holdings Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPCE#NYSE">SPCE</a>) shares are ripping higher in Thursday&#8217;s after-hours session after the company reported better-than-expected financial results <a href="https://www.benzinga.com/pressreleases/25/05/b45451181/virgin-galactic-announces-first-quarter-2025-financial-results-and-provides-business-update">for the first quarter</a>.
Q1 Earnings: Virgin Galactic reported first-quarter revenue of $461,000, beating <a href="http://benzinga.com/quote/SPCE/earnings">estimates</a> of $285,710, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>. The aerospace and space travel company reported a first-quarter loss of $2.38 per share, beating estimates for a loss of $2.55 per share.
Total revenue was down from $2 million in the prior year&#8217;s quarter due to a pause in commercial spaceflights in an effort to focus on production of its Delta Class SpaceShips. Virgin Galactic said its first spaceflight with the new SpaceShip carrying research payloads is planned for summer 2026. 
The company plans to open future astronaut sales in the first quarter of 2026, with private astronaut spaceflights planned for fall 2026.
Virgin Galactic said it generated&nbsp;$31 million&nbsp;in gross proceeds through the issuance of 6.9 million in an at-the-market offering during the quarter and ended the period with $567 million in cash, cash equivalents and marketable securities.
&#8220;The assets being built as we march through our pre-revenue phase are tremendous, and we expect them to open up a powerful and profitable business model that will benefit from an industry-leading cost structure, fixed-cost leverage as we scale, and an unparalleled customer experience,&#8221; said Michael Colglazier, CEO of Virgin Galactic.
Virgin Galactic guided for second-quarter free cash flow of negative $105 million to negative $115 million, versus negative $122 million in the first quarter. 
Virgin Galactic executives will further discuss the quarter on a conference call set to begin at 5 p.m. ET.
SPCE Price Action: <a href="http://benzinga.com/quote/SPCE">Virgin Galactic shares</a> were up 15.82% after-hours, trading at $3.88 at the time of publication Thursday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/contracts/25/05/45434506/rocket-lab-gets-nasa-contract-to-launch-aspera-astrophysics-mission">Rocket Lab Gets NASA Contract To Launch Aspera Astrophysics Mission</a></li>
</ul>
Photo: courtesy of Virgin Galactic.

SPACE

Guidance

After-Hours Center

Movers

SPCE

Virgin Galactic Stock Rockets Higher On Q1 Earnings Beat

Cenovus Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVE#NYSE">CVE</a>) has outperformed the market over the past 5 years by 12.62% on an annualized basis producing an average annual return of 27.74%. Currently, Cenovus Energy has a market capitalization of $24.63 billion. 
Buying $100 In CVE: If an investor had bought $100 of CVE stock 5 years ago, it would be worth $307.21 today based on a price of $13.58 for CVE at the time of writing.
<h3>Cenovus Energy's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1747343711_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

Here's How Much $100 Invested In Cenovus Energy 5 Years Ago Would Be Worth Today

Skeena Resources (TSX:<a class="ticker" href="https://www.benzinga.com/stock/SKE#TSX">SKE</a>) reported quarterly losses of $(0.36) per share which missed the analyst consensus estimate of $(0.03) by 1100 percent. This is a 20 percent decrease over losses of $(0.30) per share from the same period last year.

TSX:SKE

Skeena Resources Q1 EPS $(0.36) Misses $(0.03) Estimate

Offerings

Lithium Americas Files For Mixed Shelf Of Up To $1.0B

XBP Europe Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XBP#NASDAQ">XBP</a>) reported quarterly losses of $(0.12) per share. This is a 300 percent decrease over losses of $(0.03) per share from the same period last year. The company reported $37.53 million in sales this quarter. This is a 1.36 percent decrease over sales of $38.05 million the same period last year.

XBP Europe Holdings Q1 EPS $(0.12) Down From $(0.03) YoY, Sales $37.53M Down From $38.05M YoY

Callan Jmb (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CJMB#NASDAQ">CJMB</a>) reported quarterly losses of $(0.32) per share. This is a 966.67 percent decrease over losses of $(0.03) per share from the same period last year. The company reported $1.45 million in sales this quarter. This is a 19.05 percent decrease over sales of $1.79 million the same period last year.

CJMB

Callan Jmb Q1 EPS $(0.32) Down From $(0.03) YoY, Sales $1.45M Down From $1.79M YoY

South Bow (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOBO#NYSE">SOBO</a>) reported quarterly earnings of $0.47 per share which beat the analyst consensus estimate of $0.44 by 6.82 percent. This is a 14.55 percent decrease over earnings of $0.55 per share from the same period last year. The company reported quarterly sales of $498.00 million which missed the analyst consensus estimate of $527.00 million by 5.50 percent. This is a 8.46 percent decrease over sales of $544.00 million the same period last year.

SOBO

South Bow Q1 Adj. EPS $0.47 Beats $0.44 Estimate, Sales $498.00M Miss $527.00M Estimate

As legendary investor Warren Buffett prepares to step down as CEO of Berkshire Hathaway Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>) by <a href="https://www.benzinga.com/25/05/45184410/warren-buffett-to-step-down-as-berkshire-hathaway-ceo-by-end-of-year-asks-board-to-confirm-greg-abel-as-successor">the end of 2025</a>, a 13F filing released on Thursday reveals how his team reshaped the firm's portfolio in the first quarter.
What Happened: The 13F <a href="https://www.sec.gov/Archives/edgar/data/1067983/000095012325005701/0000950123-25-005701-index.html">filing </a>from Berkshire Hathaway Inc., showing the firm&#8217;s holdings as of March 31, reveals several stocks positioned exited completely, with no new stock purchases in the quarter.
Buffett and team exited positions in financial companies Citigroup (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/C#NYSE">C</a>) and Nu Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NU#NYSE">NU</a>) completely in the quarter.
The exit of Nu Holdings stock in the quarter could be a significant storyline as the investment gave Buffett exposure to digital banks in Latin America and also gave the famous Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) skeptic <a href="https://www.benzinga.com/markets/cryptocurrency/22/05/27208096/warren-buffett-now-owns-bitcoin-heres-how-the-oracle-of-omaha-got-exposure-3" target="_blank" rel="noopener">exposure to Bitcoin.</a> Nu holds the leading cryptocurrency on its balance sheet and has several crypto platforms for investors.
Here are the top decreased <a href="https://13f.info/manager/0001067983-berkshire-hathaway-inc">stakes </a>by Berkshire Hathaway in the first quarter by percentage:
<ul class="wp-block-list">
<li>Citigroup: -100%</li>
<li>Nu Holdings: -100%</li>
<li>Formula One (NASDA:FWONK): -48%</li>
<li>T-Mobile US (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMUS#NASDAQ">TMUS</a>): -11%</li>
<li>Bank of America (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>): -7%</li>
<li>Capital One Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COF#NYSE">COF</a>): -4%</li>
<li>DaVita Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DVA#NYSE">DVA</a>): -3%</li>
<li>Charter Communications (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHTR#NASDAQ">CHTR</a>): declined by less than 1%</li>
</ul>
Read Also:<a href="https://www.benzinga.com/general/education/25/05/45208955/warren-buffetts-giant-berkshire-portfolio-top-10-includes-banks-oil-and-apple"> Warren Buffett&#8217;s Giant Berkshire Portfolio: Top 10 Includes Banks, Oil, And Apple</a>
Top Additions: While Berkshire Hathaway did not make new stock purchases in the quarter, the conglomerate added to several existing positions,<a href="https://www.benzinga.com/markets/equities/24/11/41993666/warren-buffetts-berkshire-hathaway-slashes-apple-bofa-holdings-adds-dominos-pizza-in-q3"> including recent holdings</a> like Pool Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/POOL#NASDAQ">POOL</a>) and Constellation Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STZ#NYSE">STZ</a>).
Here are the top additions in the first quarter by percentage:
<ul class="wp-block-list">
<li>Pool Corporation: +145%</li>
<li>Constellation Brands: +114%</li>
<li>Heico Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HEI#NYSE">HEI</a>): +11%</li>
<li>Domino's Pizza (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DPZ#NASDAQ">DPZ</a>): +10%</li>
<li>Sirius XM Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIRI#NASDAQ">SIRI</a>): +2%</li>
<li>Occidental Petroleum (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OXY#NYSE">OXY</a>): increased by less than 1%</li>
<li>VeriSign Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRSN#NASDAQ">VRSN</a>): increase by less than 1%</li>
</ul>
Berkshire's top five holdings remain the same in Apple Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), American Express (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXP#NYSE">AXP</a>), Coca-Cola Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KO#NYSE">KO</a>), Bank of America and Chevron (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVX#NYSE">CVX</a>). Of the five, only Bank of America was changed in the quarter with the decrease.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45232692/if-you-invested-1000-in-berkshire-hathaway-stock-when-warren-buffett-did-heres-how-much-youd-have-now">If You Invested $1,000 In Berkshire Hathaway Stock When Warren Buffett Did, Here&#8217;s How Much You&#8217;d Have Now</a></li>
</ul>
Image created using artificial intelligence via Midjourney.

Management

$BTC

AAPL

CHTR

FWONK

POOL

SIRI

TMUS

VRSN

Warren Buffett Ditches Bitcoin-Linked Nu Holdings, Adds To Constellation Brands, Domino's Pizza, Pool Corp Stakes

XBP Europe Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XBP#NASDAQ">XBP</a>) reported quarterly losses of $(0.14) per share. This is a 100 percent decrease over losses of $(0.07) per share from the same period last year. The company reported $37.53 million in sales this quarter. This is a 1.36 percent decrease over sales of $38.05 million the same period last year.

XBP Europe Holdings Q1 EPS $(0.14) Down From $(0.07) YoY, Sales $37.53M Down From $38.05M YoY

Retractable Technologies (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/RVP#AMEX">RVP</a>) reported quarterly losses of $(0.35) per share. This is a 3600 percent decrease over earnings of $0.01 per share from the same period last year. The company reported $8.30 million in sales this quarter. This is a 9.16 percent increase over sales of $7.60 million the same period last year.

Retractable Technologies Q1 EPS $(0.35) Down From $0.01 YoY, Sales $8.30M Up From $7.60M YoY

WIIM

WidePoint shares are trading lower after the company reported worse-than-expected Q1 financial results and issued FY25 sales guidance below estimates.

<h3>Gainers</h3>
<ul>
<li>Oriental Culture Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OCG#NASDAQ">OCG</a>) stock moved upwards by 12.5% to $6.12 during Thursday's after-market session. The company's market cap stands at $113.6 million. </li>
<li>Arena Group Holdings (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AREN#AMEX">AREN</a>) stock moved upwards by 9.53% to $7.35. The company's market cap stands at $349.5 million. As per the press release, Q1 earnings came out today. </li>
<li>Advantage Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADV#NASDAQ">ADV</a>) shares increased by 8.24% to $1.18. The market value of their outstanding shares is at $382.6 million. As per the press release, Q1 earnings came out 3 days ago. </li>
<li>Treasure Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TGL#NASDAQ">TGL</a>) stock rose 7.69% to $1.96. The company's market cap stands at $3.1 million. </li>
<li>Direct Digital Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DRCT#NASDAQ">DRCT</a>) shares moved upwards by 5.98% to $0.53. The company's market cap stands at $10.0 million. </li>
<li>Blue Hat Interactive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BHAT#NASDAQ">BHAT</a>) stock moved upwards by 4.37% to $1.9. The market value of their outstanding shares is at $9.3 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>BloomZ (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLMZ#NASDAQ">BLMZ</a>) stock declined by 18.3% to $0.1 during Thursday's after-market session. The company's market cap stands at $1.3 million. </li>
<li>Fluent (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLNT#NASDAQ">FLNT</a>) stock declined by 10.98% to $2.15. The market value of their outstanding shares is at $41.6 million. The company's, Q1 earnings came out today. </li>
<li>LiveOne (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LVO#NASDAQ">LVO</a>) stock decreased by 6.65% to $0.84. The company's market cap stands at $80.7 million. </li>
<li>iHeartMedia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IHRT#NASDAQ">IHRT</a>) stock fell 4.77% to $1.2. The company's market cap stands at $176.4 million. As per the news, the Q1 earnings report came out 3 days ago. </li>
<li>iOThree (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IOTR#NASDAQ">IOTR</a>) shares fell 4.54% to $0.45. The company's market cap stands at $11.5 million. </li>
<li>Entravision Comms (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EVC#NYSE">EVC</a>) shares decreased by 4.54% to $1.85. The company's market cap stands at $168.4 million. 
See Also: <a href="http://www.benzinga.com/money/best-communication-services-stocks/" title="www.benzinga.com/money/best-communication-services-stocks/">www.benzinga.com/money/best-communication-services-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AREN

BHAT

BLMZ

DRCT

FLNT

IHRT

IOTR

12 Communication Services Stocks Moving In Thursday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Cabaletta Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CABA#NASDAQ">CABA</a>) stock rose 18.2% to $2.14 during Thursday's after-market session. The company's market cap stands at $104.5 million. </li>
<li>Meihua Intl Medical Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MHUA#NASDAQ">MHUA</a>) stock increased by 13.8% to $0.41. The market value of their outstanding shares is at $10.4 million. </li>
<li>Jaguar Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JAGX#NASDAQ">JAGX</a>) stock increased by 13.34% to $6.2. The company's market cap stands at $4.1 million. The company's, Q1 earnings came out today. </li>
<li>Emergent BioSolutions (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EBS#NYSE">EBS</a>) stock rose 12.02% to $6.15. The market value of their outstanding shares is at $333.8 million. </li>
<li>Inspire Veterinary (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IVP#NASDAQ">IVP</a>) stock increased by 9.36% to $1.81. The company's market cap stands at $2.6 million. </li>
<li>Sensus Healthcare (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRTS#NASDAQ">SRTS</a>) stock rose 9.22% to $5.09. The company's market cap stands at $83.4 million. The company's, Q1 earnings came out today. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Healthcare Triangle (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCTI#NASDAQ">HCTI</a>) shares fell 69.4% to $0.01 during Thursday's after-market session. </li>
<li>Doximity (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOCS#NYSE">DOCS</a>) shares decreased by 24.74% to $43.99. The company's market cap stands at $8.2 billion. As per the press release, Q4 earnings came out today. </li>
<li>Travere Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TVTX#NASDAQ">TVTX</a>) stock fell 24.32% to $16.0. The market value of their outstanding shares is at $1.4 billion. </li>
<li>Abpro Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABP#NASDAQ">ABP</a>) shares declined by 10.98% to $0.24. The company's market cap stands at $12.3 million. </li>
<li>Taysha Gene Therapies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSHA#NASDAQ">TSHA</a>) shares declined by 8.99% to $2.33. The market value of their outstanding shares is at $477.7 million. As per the news, the Q1 earnings report came out today. </li>
<li>Q32 Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QTTB#NASDAQ">QTTB</a>) stock declined by 8.05% to $1.6. The market value of their outstanding shares is at $19.5 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CABA

DOCS

HCTI

JAGX

MHUA

QTTB

SRTS

TSHA

TVTX

12 Health Care Stocks Moving In Thursday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Virgin Galactic Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPCE#NYSE">SPCE</a>) stock rose 22.4% to $4.1 during Thursday's after-market session. The company's market cap stands at $167.3 million. The company's, Q1 earnings came out today. </li>
<li>Graphjet Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTI#NASDAQ">GTI</a>) shares increased by 13.6% to $0.17. The market value of their outstanding shares is at $24.5 million. </li>
<li>Sunrise New Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EPOW#NASDAQ">EPOW</a>) stock increased by 8.69% to $1.0. The company's market cap stands at $26.1 million. </li>
<li>GrafTech International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EAF#NYSE">EAF</a>) shares rose 6.69% to $0.9. The market value of their outstanding shares is at $232.3 million. </li>
<li>Galaxy Payroll Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLXG#NASDAQ">GLXG</a>) stock rose 6.19% to $0.63. The market value of their outstanding shares is at $11.2 million. </li>
<li>Smart Powerr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CREG#NASDAQ">CREG</a>) shares moved upwards by 5.2% to $0.7. The company's market cap stands at $17.2 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Click Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLIK#NASDAQ">CLIK</a>) shares fell 21.8% to $0.56 during Thursday's after-market session. The market value of their outstanding shares is at $17.5 million. </li>
<li>KULR Technology Group (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/KULR#AMEX">KULR</a>) stock declined by 11.49% to $1.31. The company's market cap stands at $313.4 million. As per the news, the Q1 earnings report came out today. </li>
<li>Addentax Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATXG#NASDAQ">ATXG</a>) stock declined by 9.99% to $0.6. The company's market cap stands at $3.6 million. </li>
<li>Beam Glb (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BEEM#NASDAQ">BEEM</a>) shares decreased by 7.11% to $1.83. The company's market cap stands at $28.3 million. As per the press release, Q1 earnings came out today. </li>
<li>Complete Solaria (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPWR#NASDAQ">SPWR</a>) shares decreased by 5.92% to $1.75. The company's market cap stands at $129.0 million. </li>
<li>New Horizon Aircraft (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOVR#NASDAQ">HOVR</a>) stock decreased by 4.93% to $0.56. The company's market cap stands at $17.5 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ATXG

BEEM

CLIK

CREG

Sunrise New Energy Co., Ltd - Ordinary Shares

EPOW

GLXG

HOVR

KULR

SPWR

12 Industrials Stocks Moving In Thursday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>TSS (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSSI#NASDAQ">TSSI</a>) stock moved upwards by 33.5% to $11.84 during Thursday's after-market session. The company's market cap stands at $266.0 million. The company's, Q1 earnings came out today. </li>
<li>ZenaTech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZENA#NASDAQ">ZENA</a>) stock rose 15.52% to $2.53. The company's market cap stands at $64.5 million. </li>
<li>UTime (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTO#NASDAQ">WTO</a>) stock increased by 7.77% to $2.08. The market value of their outstanding shares is at $53.7 million. </li>
<li>Glimpse Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRAR#NASDAQ">VRAR</a>) shares rose 7.29% to $1.47. The company's market cap stands at $30.9 million. As per the press release, Q3 earnings came out today. </li>
<li>Aeluma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALMU#NASDAQ">ALMU</a>) stock increased by 7.03% to $13.08. The market value of their outstanding shares is at $160.2 million. </li>
<li>Quantum Computing (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QUBT#NASDAQ">QUBT</a>) stock increased by 5.3% to $9.73. The company's market cap stands at $1.3 billion. The company's, Q1 earnings came out today. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Globant (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLOB#NYSE">GLOB</a>) stock fell 25.9% to $98.5 during Thursday's after-market session. The market value of their outstanding shares is at $4.3 billion. As per the press release, Q1 earnings came out today. </li>
<li>CISO Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CISO#NASDAQ">CISO</a>) stock fell 22.32% to $0.94. The company's market cap stands at $13.6 million. </li>
<li>WidePoint (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/WYY#AMEX">WYY</a>) shares decreased by 10.95% to $4.72. The market value of their outstanding shares is at $46.1 million. As per the press release, Q1 earnings came out today. </li>
<li>Digital Ally (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DGLY#NASDAQ">DGLY</a>) stock decreased by 8.63% to $0.04. </li>
<li>Next Technology Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXTT#NASDAQ">NXTT</a>) stock fell 8.24% to $2.34. The market value of their outstanding shares is at $16.3 million. The company's, Q1 earnings came out 4 days ago. </li>
<li>Indie Semiconductor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INDI#NASDAQ">INDI</a>) stock fell 5.47% to $2.63. The market value of their outstanding shares is at $512.1 million. The company's, Q1 earnings came out 3 days ago. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ALMU

CISO

DGLY

GLOB

INDI

Next Technology Holding Inc. - Ordinary Shares

NXTT

QUBT

TSSI

VRAR

ZENA

12 Information Technology Stocks Moving In Thursday's After-Market Session

Algorhythm Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIME#NASDAQ">RIME</a>) reported quarterly losses of $(4.66) per share. This is a 93.68 percent increase over losses of $(73.76) per share from the same period last year. The company reported $1.99 million in sales this quarter. This is a 17.85 percent decrease over sales of $2.43 million the same period last year.

RIME

Algorhythm Holdings Q1 EPS $(4.66) Up From $(73.76) YoY, Sales $1.99M Down From $2.43M YoY

Press Releases

Citius Pharmaceuticals Reports Productive FDA Type C Meeting to Discuss Phase 3 Mino-Lok® Program and Pathway to Approval

Citius Pharmaceuticals, Inc. Reports Fiscal Full Year 2024 Financial Results and Provides Business Update

Small Cap

Citius Oncology Engages Jefferies as Exclusive Financial Advisor to Explore Strategic Alternatives

Citius Pharmaceuticals and Citius Oncology Highlight LYMPHIR Commercial Launch Planned for the First Half of 2025

Citius Pharmaceuticals Announces $3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Contracts

Citius Pharmaceuticals and Citius Oncology Announce Unique Permanent J-Code Issued for LYMPHIR by Centers for Medicare and Medicaid Services

Citius Pharmaceuticals, Inc. Reports Fiscal First Quarter 2025 Financial Results and Provides Business Update

Citius Pharmaceuticals Announces $2 Million Registered Direct Offering of Common Stock

Citius Pharmaceuticals to Present at the Jefferies Global Healthcare Conference

Citius Pharmaceuticals, Inc. Reports Fiscal Second Quarter 2025 Financial Results and Provides Business Update

CTOR

CTXR

Adial Pharmaceuticals, Inc - Common Stock

Adial Pharmaceuticals

Addex Therapeutics Ltd - American Depositary Shares

Addex Therapeutics

Aspire Biopharma Holdings, Inc. - Common Stock

Aspire Biopharma Hldgs

Athira Pharma

Aytu BioPharma

Biofrontera

Cingulate

Cocrystal Pharma

Citius Pharmaceuticals

Evoke Pharma

Gelteq

Hoth Therapeutics

Impact BioMedical

Jaguar Health

Kiora Pharmaceuticals, Inc. - Common Stock

Kiora Pharmaceuticals

Lipocine

Lyra Therapeutics

Purple Biotech Ltd. - American Depositary Shares

Purple Biotech

ProPhase Labs

Relmada Therapeutics, Inc. - Common Stock

Relmada Therapeutics

SenesTech

Sonoma Pharmaceuticals, Inc. - Common Stock

Sonoma Pharmaceuticals

Talphera

Traws Pharma

Titan Pharmaceuticals, Inc. - Common Stock

Titan Pharma

TherapeuticsMD

D. Boral Capital

HC Wainwright & Co.

EF Hutton

Screenshot 2024-08-06 at 7.17.40 PM

Biotech

TENK

Citius Pharmaceuticals To Receive 65 Million Shares Of TenX Keane For Merger Of Citius Oncology

Screenshot 2024-07-29 at 8.39.42 PM

From fighting cancer to treating bloodstream infections, Citius Pharmaceuticals Inc. (NASDAQ:CTXR) is busy trying to solve some of the world&#39;s ills. That&#39;s picking up steam with two of its lead products close to commercialization. 

Citius Pharmaceuticals Nears Market Breakthrough With Two Leading Products

Screenshot 2024-07-24 at 5.43.01 PM

Interview

This Pharma Company Is Preparing To Launch Its Lead Candidate

Screenshot 2024-04-17 at 5.34.28 PM

Citius Pharmaceuticals (NASDAQ: CTXR) Advances Oncology Asset, Paving Way For Spin Out Of Advanced T-cell Lymphoma Treatment

Citius Pharmaceuticals shares are trading lower after the company reported worse-than-expected Q2 EPS results.

Comments

Citius Pharmaceuticals

ニュース

パートナーシップ

ベンジンガ・グローバル